Rankings
▼
Calendar
LSTA FY 2022 Earnings — Lisata Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
LSTA
Lisata Therapeutics, Inc.
$44M
FY 2022 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$58M
Net Income
-$54M
EPS (Diluted)
$-10.47
Cash Flow
Operating Cash Flow
-$21M
Free Cash Flow
-$21M
Stock-Based Comp.
$3M
Balance Sheet
Total Assets
$73M
Total Liabilities
$7M
Stockholders' Equity
$67M
Cash & Equivalents
$32M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
$0
$0
—
Operating Income
-$58M
-$29M
-98.3%
Net Income
-$54M
-$27M
-97.4%
← Q4 2021
All Quarters
Q1 2022 →